特定于T抗原的CD8+T细胞与病毒阳性默克尔细胞癌中的PD-1阻断反应有关
Ulla Kring Hansen1,2, Candice D Church3, Ana Micaela Carnaz Simões2
1Section of Experimental and Translational Immunology, Department of Health Technology, Technical University of Denmark, Kongens Lyngby, Denmark.
The Journal of clinical investigation
|April 15, 2024
概括
响应PD-1阻断疗法的梅克尔细胞癌 (MCC) 患者显示T抗原特异性T细胞增加. 人工抗原呈现支架可以促进这些T细胞的潜在采用细胞转移和改善结果.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 病毒学 病毒学
背景情况:
- 默克尔细胞癌 (MCC) 是一种罕见的,具有攻击性的皮肤癌,与默克尔细胞多瘤病毒 (MCPyV) 有关.
- 抗PD-1疗法在MCC中表现有前途,但了解相关的T细胞反应和改善非响应者的结果仍然至关重要.
- 来自MCPyV的瘤性T抗原 (T-Ags) 是MCC的关键驱动因素,也是免疫治疗的潜在标.
研究的目的:
- 在MCC患者的抗PD-1治疗期间调查T-抗原 (T-Ag) 特定的CD8+T细胞反应.
- 确定新的T-Ag表位,并评估它们与临床反应和无进展生存率的关联.
- 探索人工抗原呈现支架的潜力,以扩大T-Ag特异性T细胞的治疗用途.
主要方法:
- 在26名接受抗PD-1治疗的MCC患者中,使用DNA条形编码的pMHC多元仪追踪T-Ag反应性CD8+T细胞.
- 对33个I类HLA单元型的T细胞识别的分析,涵盖了MCPyV T-Ags.的预测HLA连接体.
- 使用人工抗原呈现支架进行T-Ag特异性T细胞的体外扩张和功能评估.
主要成果:
- 观察到广泛的T细胞对T-Ags的识别,确定了20种潜在的新型T-Ag衍生的表位.
- 增加T-Ag特异性T细胞的频率和扩大识别概况与临床反应和延长无进展生存时间密切相关.
- 人工抗原呈现支架成功增强和扩大T-Ag特异性T细胞,即使来自最初无法检测到反应的患者,也证明了瘤排斥能力.
结论:
- 针对T抗原的特异性T细胞反应与接受PD-1阻断治疗的MCC患者的临床结果有关.
- 人工抗原呈现支架代表了一种可行的策略,用于增强T-Ag特异性T细胞免疫力,用于MCC治疗.
- 向T-Ag特异性T细胞有望改善梅克尔细胞癌的治疗策略.
相关概念视频
Tumor Immunotherapy
522
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
522
T Cell Activation and Clonal Selection
716
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
716
Cytotoxic T Cells-mediated Immune Response
904
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
904
Immune Response Against Viral Pathogens
777
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
777


